Sally Bailey
Allergy & Immunology · Baltimore, MDNPI 1700815677
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $244,548 of the $343,568 with a category attached, or 71.2%. 25 manufacturers reported payments, led by Optinose US, Inc. at 28.5% of the total. 2025 is the largest year on record at $95,315, 4.7 times the $20,458 reported in 2019. Among allergy & immunology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 730 payments — averaging $470.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$98K
- Regeneron Healthcare Solutions, Inc.$84K
- Sanofi$66K
- Alk-abello, Inc$46K
- GSK$19K
- Novartis$15K
- plus $16K from 19 others
Across 1 payment — averaging $14,700 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$15K
What the payments were for
- Consulting fees$34,04110%
- Speaking & faculty fees$244,54871%
- Travel & lodging$44,02813%
- Food & beverage$20,9106%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 163 | $97,769 |
| Regeneron Healthcare Solutions, Inc. | 136 | $83,776 |
| Sanofi | 124 | $66,118 |
| Alk-abello, Inc | 105 | $45,530 |
| GSK | 54 | $19,373 |
| Novartis | 22 | $15,035 |
| Kaleo, Inc. | 26 | $4,831 |
| Grifols USA, LLC | 5 | $2,897 |
| AbbVie | 9 | $2,891 |
| Blueprint Medicines Corporation | 11 | $2,306 |
| Pfizer | 19 | $615 |
| AstraZeneca | 18 | $527 |
| Biocryst US Sales Co., LLC | 7 | $517 |
| Greer Laboratories, Inc. | 2 | $300 |
| Genentech USA, Inc. | 6 | $241 |
| Dermavant Sciences, Inc. | 2 | $219 |
| Incyte Corporation | 5 | $97 |
| Amgen | 4 | $96 |
| ADMA Biomanufacturing LLC | 2 | $90 |
| Aimmune Therapeutics, Inc. | 3 | $88 |
| CSL Behring | 1 | $81 |
| Sanofi US Services Inc. | 1 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$343,568 in reported general payments places this provider in the 95th percentile of 105 allergy & immunology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $41,896 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Baltimore
- Antoine AzarBaltimore$612K
- Eric OliverBaltimore$31K
- Melanie DispenzaBaltimore$20K
- Monika KorffBaltimore$5K
- Darya KoenigBaltimore$4K
- William LavietesBaltimore$1K
- Mark ScarupaWheaton$508K
- Manav SinglaWhite Marsh$168K
- Sudhir SekhsariaRockville$87K
- Nasim ReedyGaithersburg$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.